Subject: 
       RE: BIOTECH BREAKTHROUGH!
   Date: 
       Sat, 06 Mar 99 22:07:07 EST
  From: 
       marketwin@sdm.net.mx
    To: 
       mrpark@sdm.net.mx

Company: Endovasc Ltd., Inc.
Symbol:  E N D V
Price:   1/2 ($.50/share)
 
The April issue of the British Biotechnology Letter, Oxford,
England,states "scientists at Glaxo Wellcome have proven
the efficacy of Endovasc's PGE-1 and have submitted
to management a multi-million dollar joint venture proposal".
 
ENDV is recommended as an immediate and "STRONG BUY".

go to:

quote.yahoo.com